These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15780071)

  • 1. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
    Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Gq/G11 guanine nucleotide regulatory protein expression in a rat model of hepatocellular carcinoma: role in mitogenesis.
    McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
    Hepatology; 1999 Feb; 29(2):371-8. PubMed ID: 9918912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma.
    Kovach SJ; Price JA; Shaw CM; Theodorakis NG; McKillop IH
    J Cell Physiol; 2006 Feb; 206(2):411-9. PubMed ID: 16110470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma.
    McKillop IH; Vyas N; Schmidt CM; Cahill PA; Sitzmann JV
    Hepatology; 1999 Feb; 29(2):412-20. PubMed ID: 9918917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
    Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 augments hepatocyte growth factor-induced liver regeneration; involvement of STAT3 activation.
    Kaido T; Oe H; Imamura M
    Hepatogastroenterology; 2004; 51(60):1667-70. PubMed ID: 15532800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 induces anti-hepatitis C viral activity in liver cells.
    Zhu H; Shang X; Terada N; Liu C
    Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways.
    Leu CM; Wong FH; Chang C; Huang SF; Hu CP
    Oncogene; 2003 Oct; 22(49):7809-18. PubMed ID: 14586407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.
    Wüstefeld T; Rakemann T; Kubicka S; Manns MP; Trautwein C
    Hepatology; 2000 Sep; 32(3):514-22. PubMed ID: 10960443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
    Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes.
    Suh HN; Lee YJ; Han HJ
    J Cell Physiol; 2009 Mar; 218(3):643-52. PubMed ID: 19006119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro.
    Haughton EL; Tucker SJ; Marek CJ; Durward E; Leel V; Bascal Z; Monaghan T; Koruth M; Collie-Duguid E; Mann DA; Trim JE; Wright MC
    Gastroenterology; 2006 Jul; 131(1):194-209. PubMed ID: 16831602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
    Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Klausner A; Preston C; Holland JF; Levine AC
    Biochem Biophys Res Commun; 2002 Jan; 290(1):249-55. PubMed ID: 11779161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.